BLRX - .9619 Pre-market now at .97/1.01 BioLineRx Announces Notice of Allowance From USPTO for Patent Covering AGI-134 - a Novel Immunotherapy for Treating Solid Tumors http://stockcharts.com/c-sc/sc?s=BLRX&p=D&b=5&g=0&i=t08809260413&r=1522068113923 http://stockcharts.com/c-sc/sc?s=BLRX&p=W&b=5&g=0&i=t29969213122&r=1522068146932